Drugs that contain Maraviroc

1. List of Selzentry drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US6667314

(Pediatric)

VIIV HLTHCARE Tropane derivatives useful in therapy
Feb, 2022

(1 year, 1 month ago)

US7368460 VIIV HLTHCARE Tropane derivatives useful in therapy
Nov, 2022

(3 months ago)

US7368460

(Pediatric)

VIIV HLTHCARE Tropane derivatives useful in therapy
May, 2023

(2 months from now)

Exclusivity Exclusivity Expiration
New Patient Population (NPP) Oct 30, 2023
Pediatric Exclusivity (PED) Apr 30, 2024

Market Authorisation Date: 04 November, 2016

Treatment: Method of treating patients infected with ccr5-tropic hiv-1

Dosage: SOLUTION;ORAL

How can I launch a generic of SELZENTRY before it's patent expiration?
More Information on Dosage

SELZENTRY family patents

5

United States

3

Germany

3

Malaysia

3

Spain

3

Norway

3

China

3

Hong Kong

3

European Union

2

Portugal

2

United Kingdom

2

Austria

2

Argentina

2

Korea, Republic of

2

EA

2

Japan

2

Slovenia

2

Australia

2

Denmark

1

Turkey

1

Uruguay

1

Panama

1

Guatemala

1

Brazil

1

Croatia

1

Costa Rica

1

IB

1

New Zealand

1

AP

1

Egypt

1

Estonia

1

Mexico

1

Morocco

1

Peru

1

Taiwan, Province of China

1

Tunisia

1

South Africa

1

Slovakia

1

Lithuania

1

Canada

1

Cyprus

1

ME

1

Luxembourg

1

Czech Republic

1

Iceland

1

Israel

1

Ukraine

1

OA

1

Bulgaria

1

Georgia

1

Poland

1

Yugoslavia

1

RS

1

Algeria

1

Ecuador

1

Cuba

1

Netherlands

1

Hungary

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in